78 related articles for article (PubMed ID: 23342950)
1. Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.
Imamura Y; Umezawa N; Osawa S; Shimada N; Higo T; Yokoshima S; Fukuyama T; Iwatsubo T; Kato N; Tomita T; Higuchi T
J Med Chem; 2013 Feb; 56(4):1443-54. PubMed ID: 23342950
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
[TBL] [Abstract][Full Text] [Related]
3. Designed helical peptides inhibit an intramembrane protease.
Das C; Berezovska O; Diehl TS; Genet C; Buldyrev I; Tsai JY; Hyman BT; Wolfe MS
J Am Chem Soc; 2003 Oct; 125(39):11794-5. PubMed ID: 14505382
[TBL] [Abstract][Full Text] [Related]
4. Important functional role of residue x of the presenilin GxGD protease active site motif for APP substrate cleavage specificity and substrate selectivity of γ-secretase.
Kretner B; Fukumori A; Kuhn PH; Pérez-Revuelta BI; Lichtenthaler SF; Haass C; Steiner H
J Neurochem; 2013 Apr; 125(1):144-56. PubMed ID: 23237322
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?
Knappenberger KS; Tian G; Ye X; Sobotka-Briner C; Ghanekar SV; Greenberg BD; Scott CW
Biochemistry; 2004 May; 43(20):6208-18. PubMed ID: 15147205
[TBL] [Abstract][Full Text] [Related]
6. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.
Wu F; Schweizer C; Rudinskiy N; Taylor DM; Kazantsev A; Luthi-Carter R; Fraering PC
FASEB J; 2010 Jul; 24(7):2464-74. PubMed ID: 20237298
[TBL] [Abstract][Full Text] [Related]
7. Requirement for small side chain residues within the GxGD-motif of presenilin for gamma-secretase substrate cleavage.
Pérez-Revuelta BI; Fukumori A; Lammich S; Yamasaki A; Haass C; Steiner H
J Neurochem; 2010 Feb; 112(4):940-50. PubMed ID: 20021564
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
9. In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc.
Hoke DE; Tan JL; Ilaya NT; Culvenor JG; Smith SJ; White AR; Masters CL; Evin GM
FEBS J; 2005 Nov; 272(21):5544-57. PubMed ID: 16262694
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of γ-secretase activity by a monoclonal antibody against the extracellular hydrophilic loop of presenilin 1.
Takagi-Niidome S; Osawa S; Tomita T; Iwatsubo T
Biochemistry; 2013 Jan; 52(1):61-9. PubMed ID: 23210549
[TBL] [Abstract][Full Text] [Related]
11. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
[TBL] [Abstract][Full Text] [Related]
12. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.
Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H
Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235
[TBL] [Abstract][Full Text] [Related]
13. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
14. Substrate determinants in the C99 juxtamembrane domains differentially affect γ-secretase cleavage specificity and modulator pharmacology.
Ousson S; Saric A; Baguet A; Losberger C; Genoud S; Vilbois F; Permanne B; Hussain I; Beher D
J Neurochem; 2013 May; 125(4):610-9. PubMed ID: 23253155
[TBL] [Abstract][Full Text] [Related]
15. The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators.
Botev A; Munter LM; Wenzel R; Richter L; Althoff V; Ismer J; Gerling U; Weise C; Koksch B; Hildebrand PW; Bittl R; Multhaup G
Biochemistry; 2011 Feb; 50(5):828-35. PubMed ID: 21186781
[TBL] [Abstract][Full Text] [Related]
16. Unnatural amino acid-substituted (hydroxyethyl)urea peptidomimetics inhibit gamma-secretase and promote the neuronal differentiation of neuroblastoma cells.
Liao YF; Wang BJ; Hsu WM; Lee H; Liao CY; Wu SY; Cheng HT; Hu MK
Mol Pharmacol; 2007 Feb; 71(2):588-601. PubMed ID: 17105873
[TBL] [Abstract][Full Text] [Related]
17. Secretase inhibitors and modulators for Alzheimer's disease treatment.
Tomita T
Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting β-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP.
Boddapati S; Levites Y; Sierks MR
J Mol Biol; 2011 Jan; 405(2):436-47. PubMed ID: 21073877
[TBL] [Abstract][Full Text] [Related]
19. Construction of a small peptide library related to inhibitor OM99-2 and its structure-activity relationship to beta-secretase.
Hu B; Xiong B; Qiu BY; Li X; Yu HP; Xiao K; Wang X; Li J; Shen JK
Acta Pharmacol Sin; 2006 Dec; 27(12):1586-93. PubMed ID: 17112413
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Subnanomolar helical D-tridecapeptide inhibitor of gamma-secretase.
Bihel F; Das C; Bowman MJ; Wolfe MS
J Med Chem; 2004 Jul; 47(16):3931-3. PubMed ID: 15267231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
